Revised Draft Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products
New collection (Request for a new OMB Control Number)
No
Regular
Approved without change
08/16/2011
08/04/2011
table that charts list comparision
Inventory as of this Action
Requested
Previously Approved
08/31/2014
36 Months From Approved
94
0
0
1,524
0
0
0
0
0
This information collection request covers the collections associated with "Revised Draft Guidance for Industry on User Fee Waivers, Reductions, and Refunds for Drug and Biological Products," which provides recommendations to applicants considering whether to request a waiver or reduction in user fees assessed under Section 735 and 736 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act).
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.